Enanta Pharmaceuticals | ENTA - 貿易債権者





貿易債権者 変化する 日付
AbbVie USD 3.59B 28.65B 2025-12
Amgen USD 19.52B 1.37B 2026-03
Anika Therapeutics USD 6.34M 298K 2026-03
Arrowhead Research USD 30.75M 2.19M 2026-03
AstraZeneca USD 22.51B 2.78B 2026-03
BioCryst Pharmaceuticals USD 10.96M 4.87M 2026-03
Biogen USD 358.5M 73.5M 2026-03
Bristol-Myers Squibb USD 4.23B 659M 2026-03
Enanta Pharmaceuticals USD 1.88M 63K 2025-12
Gilead Sciences USD 645M 70M 2026-03
GlaxoSmithKline GBP 14.34B 1.05B 2026-03
Halozyme Therapeutics USD 14.1M 6.8M 2026-03
Heron Therapeutics USD 8.97M 24K 2026-03
Immunic USD 11.01M 873K 2026-03
Incyte USD 228.62M 1.41B 2026-03
Insmed USD 73.38M 6.53M 2026-03
Ionis Pharmaceuticals USD 26.03M 2.05M 2026-03
J&J USD 9.22B 1.24B 2026-06
Karyopharm Therapeutics USD 4M 1.39M 2025-12
Ligand Pharmaceuticals USD 37.11M 33.87M 2026-03
Merck USD 3.86B 541M 2026-03
Neurocrine Biosciences USD 691.3M 145.8M 2026-03
Novartis USD 4.32B 134M 2026-03
Novavax USD 16.1M 8.48M 2026-03
Pfizer USD 4.51B 734M 2026-03
PTC Therapeutics USD 25.48M 20M 2026-03
Roche Holding CHF 5.54B 237M 2026-06
Sarepta Therapeutics USD 70.38M 210.46M 2026-03
Vertex Pharmaceuticals USD 3.47B 40.6M 2026-03